Microenvironmental strategies for the optimal utilization of anti-angiogenic drugs combinations

最佳利用抗血管生成药物组合的微环境策略

• 批准号: 240119
• 负责人: Minchinton Andrew I
• 金额: $ 48.27万
• 依托单位: B.C. Cancer Research Centre (Vancouver)
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2011
• 资助国家: 加拿大
• 起止时间: 2011-09-01 至 2015-09-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=240119&lang=en
• 关键词: Angiogenesis; Chemotherapy; Hypoxia; Radiation Therapy; Tumour Microenvironment

Anti-angiogenic therapy involves treatments with drugs that inhibit the growth of blood vessels. In adults angiogenesis only occurs during wound healing, inflammation and a few other instances. Tumour growth necessitates new blood vessel development to fe

抗血管生成疗法包括使用抑制血管生长的药物进行治疗。在成人中，血管生成仅发生在伤口愈合、炎症和少数其他情况下。肿瘤生长需要新的血管发育来进行。